Global Endoscopy Ultrasound Market Size By Product Type (Radial-Endoscopic Ultrasound, Linear-Endoscopic Ultrasound ), By Application, By End-User (Hospitals, Ambulatory Surgical Centers ), By Geographic Scope And Forecast

Endoscopy Ultrasound Market Size And Forecast

Endoscopy Ultrasound Market size was valued at USD 1.18 Billion in 2024 and is projected to reach USD 1.87 Billion by 2032, growing at a CAGR of 6.5% from 2026 to 2032.

Endoscopic ultrasound (EUS) is a medical procedure that uses an endoscope and ultrasound to obtain detailed images of the digestive tract and surrounding tissues and organs, providing high-resolution imaging for diagnostic and therapeutic purposes.

Endoscopic ultrasound is widely used in the diagnosis and staging of gastrointestinal (GI) cancers, such as esophageal, pancreatic, and colorectal cancers.

It is also employed to evaluate benign conditions like pancreatitis, gallstones, and cysts. EUS enables fine-needle aspiration (FNA) to obtain tissue samples for biopsy, aiding in accurate diagnosis and treatment planning.

Additionally, therapeutic applications include drainage of pancreatic pseudocysts, celiac plexus neurolysis for pain management, and guided injections or placements of stents.

The future of endoscopic ultrasound is promising due to anticipated technological advancements that will enhance its diagnostic and therapeutic capabilities.

Global Endoscopy Ultrasound Market Dynamics

The key market dynamics that are shaping the global endoscopy ultrasound market include:

Key Market Drivers

Increasing Prevalence of Gastrointestinal Diseases: The rising incidence of GI cancers and other digestive disorders drives demand for advanced diagnostic tools like endoscopic ultrasound (EUS) to improve early detection and treatment outcomes. According to the National Cancer Institute, colorectal cancer is the third most common cancer in the United States, with an estimated 151,030 new cases in 2022.

Technological Advancements: Continuous innovations in EUS equipment, such as high-resolution imaging and minimally invasive techniques, enhance diagnostic accuracy and broaden the range of therapeutic applications, boosting market growth. The U.S. Food and Drug Administration (FDA) approved 12 new endoscopic devices in 2024, a 20% increase from the previous year, highlighting the rapid pace of innovation in this field.

Growing Adoption of Minimally Invasive Procedures: The preference for minimally invasive diagnostic and therapeutic procedures, which reduce patient recovery time and associated risks, fuels the adoption of EUS in clinical settings. The Centers for Medicare & Medicaid Services reported a 15% increase in outpatient endoscopic procedures between 2020 and 2024, reflecting this trend. EUS procedures, which reduce patient recovery time and associated risks, are becoming increasingly popular.

Rising Geriatric Population: An aging global population increases the prevalence of age-related gastrointestinal conditions, necessitating advanced diagnostic procedures like EUS for effective management and treatment. The World Health Organization projects that the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. This demographic shift is expected to drive demand for EUS procedures.

Increasing Healthcare Expenditure: Higher healthcare spending, particularly in developing regions, supports the adoption and implementation of advanced medical technologies, including EUS, improving access to quality diagnostic and therapeutic services. The World Bank reported that global health expenditure as a percentage of GDP increased from 9.7% in 2010 to 10.2% in 2022, indicating growing investment in healthcare services and technologies. This trend is improving access to quality diagnostic and therapeutic services.

Key Challenges:

Limited Availability of Skilled Professionals: The complexity of EUS procedures necessitates specialized training and expertise, and the shortage of adequately trained professionals can hinder market growth and the widespread adoption of this technology.

Stringent Regulatory Requirements: The rigorous approval processes and compliance with strict regulatory standards can delay the introduction of new EUS devices and technologies, impacting market expansion and innovation.

Risk of Complications and Adverse Effects: Although minimally invasive, EUS procedures carry risks such as infection, bleeding, and perforation, which may deter patients and healthcare providers from opting for this diagnostic method.

Competition from Alternative Imaging Modalities: The availability of other advanced imaging technologies, such as MRI and CT scans, which are also effective in diagnosing GI conditions, can limit the demand for EUS, affecting market growth.

Key Trends

Integration of Artificial Intelligence (AI): AI and machine learning are being increasingly integrated into EUS systems to enhance image analysis and interpretation, improving diagnostic accuracy and efficiency, and enabling more precise and personalized treatment plans. The National Institutes of Health (NIH) reported in 2024 that AI-assisted EUS diagnoses showed a 15% improvement in early pancreatic cancer detection compared to traditional methods. In a recent development, on July 10, 2024, Olympus Corporation announced the launch of its new AI-powered EUS platform, promising a 30% reduction in procedure time and improved lesion detection rates.

Miniaturization of Equipment: Ongoing advancements in the miniaturization of EUS probes and devices are making procedures less invasive and more comfortable for patients, expanding the range of applications and facilitating adoption in outpatient settings. The European Society of Gastrointestinal Endoscopy (ESGE) reported in 2024 that the average diameter of EUS probes decreased by 25% over the past five years, significantly reducing patient discomfort. This trend has expanded the range of EUS applications, particularly in outpatient settings.

Expansion of Therapeutic Applications: Beyond diagnostics, EUS is increasingly being utilized for therapeutic interventions, such as targeted drug delivery, cyst drainage, and tumor ablation, broadening its clinical utility and driving market growth. The American Society for Gastrointestinal Endoscopy (ASGE) reported that EUS-guided interventions increased by 40% between 2019 and 2024, with procedures like cyst drainage and tumor ablation seeing the highest growth.

Global Endoscopy Ultrasound Market Regional Analysis

Here is a more detailed regional analysis of the global endoscopy ultrasound market:

North America

North America dominating the endoscopy ultrasound market due to advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a large pool of skilled professionals. According to the Centers for Disease Control and Prevention (CDC), gastrointestinal diseases affected approximately 70 million Americans in 2022, underscoring the growing need for advanced diagnostic and therapeutic tools like EUS.

The increasing prevalence of gastrointestinal diseases and robust healthcare expenditure further drive market growth in this region. The Centers for Medicare & Medicaid Services (CMS) reported that U.S. healthcare spending reached USD 4.3 Trillion in 2024, with a notable portion allocated to advanced medical technologies like EUS. This substantial investment has facilitated the widespread adoption of cutting-edge EUS systems across healthcare institutions.

Government initiatives and funding for cancer research also contribute to the expanding use of EUS. For instance, in July 20, 2024, Pentax Medical, a key player in the EUS market, announced a partnership with a leading U.S. cancer research institute to develop a novel EUS-guided drug delivery system for pancreatic cancer treatment. This collaboration exemplifies the ongoing efforts to leverage EUS technology in advancing cancer care and solidifies North America's position at the forefront of EUS market growth.

Asia Pacific

The Asia-Pacific region is witnessing rapid growth in the endoscopic ultrasound (EUS) market, driven by substantial healthcare investments and an increasing prevalence of gastrointestinal disorders. According to the World Health Organization (WHO), healthcare spending in the Western Pacific region, which includes much of Asia, reached 6.6% of GDP in 2022, marking a significant increase from previous years.

This rising investment has directly contributed to improving healthcare infrastructure and the adoption of advanced medical technologies like EUS. The Asian Pacific Society for Digestive Endoscopy reported a 45% increase in EUS procedures across the region from 2020 to 2024, highlighting the growing acceptance and utilization of this technology.

China, Japan, and India are spearheading the expansion of the EUS market in the Asia-Pacific region. China's National Health Commission reported that the country's healthcare expenditure reached 7.12 trillion yuan (approximately USD 1.1 Trillion) in 2024, with a substantial portion allocated to upgrading medical equipment in hospitals.

The growing middle-class population and rising disposable incomes in the Asia-Pacific region are fueling the demand for advanced medical diagnostics and treatments. The Asian Development Bank estimated that 65% of the region's population will be middle class by 2025, up from 45% in 2015. This demographic shift has led to increased healthcare awareness and willingness to invest in advanced medical procedures.

Global Endoscopy Ultrasound Market: Segmentation Analysis

The Global Endoscopy Ultrasound Market is Segmented on the basis of Product Type, Application, End-User, and Geography.

Endoscopy Ultrasound Market, By Product Type

• Radial-Endoscopic Ultrasound (EUS)
• Linear-Endoscopic Ultrasound (EUS)
• Curvilinear-Endoscopic Ultrasound (EUS)
• Phased Array-Endoscopic Ultrasound (EUS)
• Doppler-Endoscopic Ultrasound (EUS)

Based on Product Type, the Global Endoscopy Ultrasound Market is bifurcated into Radial-Endoscopic Ultrasound (EUS), Linear-Endoscopic Ultrasound (EUS), Curvilinear-Endoscopic Ultrasound (EUS), Phased Array-Endoscopic Ultrasound (EUS), and Doppler-Endoscopic Ultrasound (EUS). In the endoscopy ultrasound (EUS) market, linear-endoscopic ultrasound (EUS) is currently the dominant product type due to its widespread use in gastrointestinal diagnostics, providing detailed images for precise assessments of digestive tract conditions. Radial-endoscopic ultrasound (EUS) is the second rapidly growing segment, driven by its ability to offer comprehensive views of the surrounding structures, making it increasingly popular for evaluating pancreatic and bile duct conditions. Both product types are essential for enhancing diagnostic accuracy and are witnessing growth due to advancements in technology and increasing clinical applications.

Endoscopy Ultrasound Market, By Application

• Gastroenterology
• Oncology
• Pulmonology
• Gynecology
• Urology

Based on Application, the Global Endoscopy Ultrasound Market is bifurcated into Gastroenterology, Oncology, Pulmonology, Gynecology, and Urology. In the endoscopy ultrasound (EUS) market, gastroenterology is the dominant application due to its extensive use in diagnosing and managing gastrointestinal conditions, such as cancers, pancreatitis, and bile duct abnormalities. Oncology is the second rapidly growing application, driven by the increasing need for precise staging and diagnosis of cancers, particularly in organs such as the pancreas and rectum, where EUS provides critical imaging for effective treatment planning and monitoring. Both applications are crucial in advancing diagnostic capabilities and improving patient outcomes in their respective fields.

Endoscopy Ultrasound Market, By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Clinics

Based on End-User, the Global Endoscopy Ultrasound Market is bifurcated into Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostic Centers, and Clinics. In the endoscopy ultrasound (EUS) market, hospitals are the dominant end-user due to their comprehensive facilities and high volume of diagnostic and therapeutic procedures, which leverage EUS technology for advanced patient care. Ambulatory Surgical Centers (ASCs) are the second rapidly growing end-user, driven by the increasing preference for outpatient procedures and the need for minimally invasive diagnostics and treatments. ASCs offer a convenient and cost-effective setting for EUS procedures, contributing to their expanding role in the market.

Endoscopy Ultrasound Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Endoscopy Ultrasound Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In the endoscopy ultrasound (EUS) market, North America is the dominant region, driven by its advanced healthcare infrastructure, high adoption of innovative medical technologies, and substantial healthcare expenditure. Asia-Pacific is the second rapidly growing region, fueled by increasing healthcare investments, rising prevalence of gastrointestinal disorders, and expanding healthcare infrastructure in countries like China, Japan, and India. The rapid growth in Asia-Pacific is supported by a rising middle-class population and greater accessibility to advanced medical diagnostics.

Key Players

The "Global Endoscopy Ultrasound Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Olympus Corporation, PENTAX Medical (HOYA Corporation), FUJIFILM Corporation, Hitachi Medical Systems, Boston Scientific Corporation, Cook Medical, Medtronic, CONMED Corporation, Medi-Globe GmbH, Limaca Medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Endoscopy Ultrasound Market Key Developments

• In September 2024, Olympus Corporation introduced the UEV-400, a next-generation endoscopic ultrasound system featuring enhanced imaging resolution and real-time 3D visualization capabilities, aimed at improving diagnostic accuracy in gastrointestinal procedures.
• In June 2024, Fujifilm unveiled the EG-740UT, a new endoscopic ultrasound device with advanced needle guidance technology, designed to facilitate more precise biopsies and reduce procedure time in oncology applications.
• In March 2024, Pentax Medical announced a major upgrade to its EUS system with the release of the i-scan 3D, which integrates artificial intelligence to enhance image clarity and assist in the early detection of abnormalities.